Arthritis

Cardiovascular·MeSH: Arthritis

Prevalence

800.0 / 100K

Incidence

41.0 / 100K/yr

224 drugs in development·108 companies·4 clinical trials

Drug Pipeline by Phase

Approved(52)

Drug	Company
abrilada	PFIZER INC (PFE)
acetaminophen	DR REDDYS LABORATORIES LTD (RDY)
acetaminophen	GT Biopharma, Inc. (GTBP)
amjevita	AMGEN INC (AMGN)
Brenzys (SB4)	Organon & Co. (OGN)
celecoxib	Aptinyx Inc. (APTX)
celecoxib	ACADIA PHARMACEUTICALS INC (ACAD)
celecoxib	Miromatrix Medical Inc. (MIRO)
celecoxib	AlphaTON Capital Corp (ATON)
celecoxib	Zomedica Corp. (ZOMDF)
Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
Cymbalta®	ELI LILLY & Co (LLY)
diclofenac	Aptinyx Inc. (APTX)
diclofenac	SUNSET ISLAND GROUP (SUN)
diclofenac	Miromatrix Medical Inc. (MIRO)
galliprant	ARATANA THERAPEUTICS, INC. (PETX)
genvisc	Avanos Medical Inc. (AVNS)
Hadlima (SB5)	Organon & Co. (OGN)
ibuprofen	CHINA PHARMA HOLDINGS, INC. (CPHI)
ibuprofen	AERIE PHARMACEUTICALS INC (AERI)
ibuprofen	PATHEON N.V. (PTI)
ibuprofen	GT Biopharma, Inc. (GTBP)
imuldosa	Acorda Therapeutics, Inc. (ACOR)
indocin	Zyla Life Sciences (ZCOR)
indocin	Assertio Holdings, Inc. (ASRT)
INDOCIN (suppositories and oral suspension)	Assertio Holdings, Inc. (ASRT)
INDOCIN Oral Suspension	Assertio Holdings, Inc. (ASRT)
INDOCIN Suppositories	Assertio Holdings, Inc. (ASRT)
indomethacin	Mylan II B.V. (MYL)
indomethacin	Amneal Pharmaceuticals, Inc. (AMRX)
inFoods® (IBS)	BIOMERICA INC (BMRA)
iovera°	Pacira BioSciences, Inc. (PCRX)
iovera° system	Pacira BioSciences, Inc. (PCRX)
meloxicam	Mylan II B.V. (MYL)
methotrexate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
Olumiant	ELI LILLY & Co (LLY)
Olumiant®	ELI LILLY & Co (LLY)
Otrexup	Assertio Holdings, Inc. (ASRT)
Purified Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
Renflexis (SB2)	Organon & Co. (OGN)
sodium	Ginkgo Bioworks Holdings Inc. (DNA)
Taltz	ELI LILLY & Co (LLY)
Taltz®	ELI LILLY & Co (LLY)
tofidence	BIOGEN INC. (BIIB)
Tremfya	Royalty Pharma plc (RPRX)
vivlodex	Zyla Life Sciences (ZCOR)
wezlana	AMGEN INC (AMGN)
xeljanz xr	PFIZER INC (PFE)
yesintek	Bone Biologics Corp (BBLG)
zilretta	Flexion Therapeutics Inc (FLXN)
ZILRETTA	Pacira BioSciences, Inc. (PCRX)
zorvolex	Zyla Life Sciences (ZCOR)

Phase 3(40)

Drug	Company
Abatacept	Crinetics Pharmaceuticals, Inc. (CRNX)
Abatacept	ENANTA PHARMACEUTICALS INC (ENTA)
Abatacept	Cidara Therapeutics, Inc. (CDTX)
abx464	Abivax SA (ABVX)
ABX464	Abivax SA (ABVX)
adalimumab	GT Biopharma, Inc. (GTBP)
adalimumab	ELI LILLY & Co (LLY)
Adalimumab	AbbVie Inc. (ABBV)
Apitox (Apitoxin in South Korea)	Apimeds Pharmaceuticals US, Inc. (APUS)
BGB-45035	BeOne Medicines Ltd. (ONC)
Bimekizumab	Crinetics Pharmaceuticals, Inc. (CRNX)
Eloralintide	ELI LILLY & Co (LLY)
Guselkumab	Crinetics Pharmaceuticals, Inc. (CRNX)
icotrokinra	GH Research PLC (GHRS)
Ixekizumab	ELI LILLY & Co (LLY)
Ketorolac	Clearside Biomedical, Inc. (CLSDQ)
leflunomide	Sanofi (SNY)
leflunomide	Sanofi (SNYNF)
lorecivivint	TG THERAPEUTICS, INC. (TGTX)
Lutikizumab	AbbVie Inc. (ABBV)
Platelet Rich Plasma Injection	UNITED THERAPEUTICS Corp (UTHR)
plx-pad	Pluri Inc. (PLUR)
ptp-01	Horizon Therapeutics Public Ltd Co (HZNP)
qingzhu granules	NYMOX PHARMACEUTICAL CORP (NYMXF)
ranevetmab	Nexvet Biopharma plc (NVET)
risankizumab	POINT Biopharma Global Inc. (PNT)
risankizumab	GT Biopharma, Inc. (GTBP)
Risankizumab	Crinetics Pharmaceuticals, Inc. (CRNX)
Risankizumab	MoonLake Immunotherapeutics (MLTX)
secukinumab	Novartis AG (NVS)
secukinumab	Novartis AG (NVS)
tc99m tilmanocept	NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
tlc599	Endo International plc (ENDP)
Tocilizumab	AbbVie Inc. (ABBV)
Tocilizumab	ELI LILLY & Co (LLY)
Tocilizumab	Cidara Therapeutics, Inc. (CDTX)
Triamcinolone	Valneva SE (VALN)
ustekinumab dose based on bsa	GH Research PLC (GHRS)
zilretta	West Pharmaceutical Services Inc. (WST)
ZILRETTA (shoulder indication)	Pacira BioSciences, Inc. (PCRX)

Phase 2(60)

Drug	Company
[prp] platelet rich plasma	HWH International Inc. (HWH)
[stromed + platelet rich plasma]	HWH International Inc. (HWH)
Abiprubart	Kiniksa Pharmaceuticals International, plc (KNSA)
ACP-044 Dose A	ACADIA PHARMACEUTICALS INC (ACAD)
ACP-044 Dose B	ACADIA PHARMACEUTICALS INC (ACAD)
allocetra	Enlivex Ltd. (ENLV)
allogeneic nk cells	Artiva Biotherapeutics, Inc. (ARTV)
allojoin	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
allonk	Artiva Biotherapeutics, Inc. (ARTV)
amt-101	Applied Molecular Transport Inc. (AMTI)
AZD1163	ASTRAZENECA PLC (AZN)
BGB-45035	Crinetics Pharmaceuticals, Inc. (CRNX)
bimekizumab	POINT Biopharma Global Inc. (PNT)
bimekizumab	GT Biopharma, Inc. (GTBP)
cenplacel-l	Celularity Inc. (CELU)
dfv890	Novartis AG (NVS)
enekinragene inzadenovec	ACURA PHARMACEUTICALS, INC (ACUR)
eq121	EQRx, Inc. (EQRX)
frunevetmab	Nexvet Biopharma plc (NVET)
hydroxychloroquine	Incannex Healthcare Inc. (IXHL)
ihl-675a	Incannex Healthcare Inc. (IXHL)
imvotamab	IGM Biosciences, Inc. (IGMS)
isomyosamine	Q/C TECHNOLOGIES, INC. (QCLS)
izokibep	ACELYRIN, Inc. (SLRN)
jade201	Jade Biosciences, Inc. (JBIO)
jnj-88545223	GH Research PLC (GHRS)
Kevzara	REGENERON PHARMACEUTICALS, INC. (REGN)
lna043	NOVARTIS AG (NVSEF)
lna043	Novartis AG (NVS)
LY3016859 ISA	ELI LILLY & Co (LLY)
LY3526318 ISA	ELI LILLY & Co (LLY)
ly3541860	ELI LILLY & Co (LLY)
LY3556050 ISA	ELI LILLY & Co (LLY)
LY3857210 ISA	ELI LILLY & Co (LLY)
ly3871801	ELI LILLY & Co (LLY)
LY4065967	ELI LILLY & Co (LLY)
natrunix	XBiotech Inc. (XBIT)
ocadusertib	RIGEL PHARMACEUTICALS INC (RIGL)
PIPE-307	Contineum Therapeutics, Inc. (CTNM)
PIPE-791	Contineum Therapeutics, Inc. (CTNM)
quc398	Novartis AG (NVS)
quc398	NOVARTIS AG (NVSEF)
r552	RIGEL PHARMACEUTICALS INC (RIGL)
rapcabtagene autoleucel	Novartis AG (NVS)
rapcabtagene autoleucel	Novartis AG (NVS)
Ravagalimab	AbbVie Inc. (ABBV)
rejoin	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
resiniferatoxin	Sorrento Therapeutics, Inc. (SRNE)
rhh646	Novartis AG (NVS)
RHH646	Novartis AG (NVS)
sar441566	Sanofi (SNY)
SAR441566	Sanofi (SNY)
sarilumab sar153191	Sanofi (SNY)
sarilumab sar153191	Sanofi (SNY)
SLK	MoonLake Immunotherapeutics (MLTX)
spy002-072	Spyre Therapeutics, Inc. (SYRE)
SPY072	Spyre Therapeutics, Inc. (SYRE)
Tulisokibart	Merck & Co., Inc. (MRK)
Upadacitinib	ENANTA PHARMACEUTICALS INC (ENTA)
vilamakitug	XBiotech Inc. (XBIT)

Phase 1(17)

Drug	Company
allogeneic engineered gingival fibroblasts	TG THERAPEUTICS, INC. (TGTX)
amt-126	Applied Molecular Transport Inc. (AMTI)
dfv890	Novartis AG (NVS)
fx201	Flexion Therapeutics Inc (FLXN)
ly3009104	ELI LILLY & Co (LLY)
ly4213663	ELI LILLY & Co (LLY)
pit565	Novartis AG (NVS)
pit565	Novartis AG (NVS)
plamotamab	Xencor Inc (XNCR)
PN-881	Protagonist Therapeutics, Inc (PTGX)
prula-cel	Adicet Bio, Inc. (ACET)
raphael's formula	Raphael Pharmaceutical Inc. (RAPH)
sar446959	Sanofi (SNY)
sbt777101	Sonoma Pharmaceuticals, Inc. (SNOA)
sbt777101	SAB BIOTHERAPEUTICS, INC. (SABS)
Sonelokimab	MoonLake Immunotherapeutics (MLTX)
vyn202	VYNE Therapeutics Inc. (VYNE)

Preclinical(21)

Drug	Company
AR-300	Ampio Pharmaceuticals, Inc. (AMPE)
CM6336	CalciMedica, Inc. (CALC)
CPI-182	Corvus Pharmaceuticals, Inc. (CRVS)
epidiferphane	UNITED CANNABIS CORP (CNAB)
epoladerm	Virpax Pharmaceuticals, Inc. (VRPX)
joint pain/arthritis formulation	HEALTH-RIGHT DISCOVERIES, INC. (HRDV)
kl-009	Luckwel Pharmaceuticals Inc. (LKYM)
kl-2120	Luckwel Pharmaceuticals Inc. (LKYM)
KT-294	Kymera Therapeutics, Inc. (KYMR)
L.E.A.P.S.	CEL SCI CORP (CVM)
L.E.A.P.S. (Ligand Epitope Antigen Presentation System)	CEL SCI CORP (CVM)
labp-69	Landos Biopharma, Inc. (LABP)
OA-201	Ampio Pharmaceuticals, Inc. (AMPE)
phoenix auto	Phoenix Life Sciences International Limited. (PLSI)
prana bio nutrient medicinals	UNITED CANNABIS CORP (CNAB)
ra product candidate	Raphael Pharmaceutical Inc. (RAPH)
rpi-78	NUTRA PHARMA CORP (NPHC)
rpi-78m	NUTRA PHARMA CORP (NPHC)
rt-105	Rani Therapeutics Holdings, Inc. (RANI)
zan-200	ENTEST GROUP, INC. (ETNI)
zan-200	ZANDER THERAPEUTICS, INC (ZANDER)

Unknown(6)

Drug	Company
Ampion®	Ampio Pharmaceuticals, Inc. (AMPE)
Biologic or targeted synthetic DMARD	UNITED THERAPEUTICS Corp (UTHR)
InFoods® platform (other disease targets)	BIOMERICA INC (BMRA)
orencia	BRISTOL MYERS SQUIBB CO (BMY)
TCR discovery collaboration (non-exclusive agreements)	Adaptive Biotechnologies Corp (ADPT)
tnf-α antagonists	HCW Biologics Inc. (HCWB)

BLA Filed(2)

Drug	Company
Icotyde	Protagonist Therapeutics, Inc (PTGX)
m923	MOMENTA PHARMACEUTICALS INC (MNTA)

N/A(1)

Drug	Company
Apremilast	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2/Phase 3(1)

Drug	Company
imvt-1402	Roivant Sciences Ltd. (ROIV)

Phase 4(24)

Drug	Company
Adalimumab	ENANTA PHARMACEUTICALS INC (ENTA)
Anti-Tumor Necrosis Factor Alpha Drug	Galapagos NV (GLPG)
bms-986454	BRISTOL MYERS SQUIBB CO (BMY)
bms-986528	BRISTOL MYERS SQUIBB CO (BMY)
Botulinum Toxin A	Revance Therapeutics, Inc. (RVNC)
Deucravacitinib	Valneva SE (VALN)
Deucravacitinib	BRISTOL MYERS SQUIBB CO (BMY)
DPP-4 inhibitor	ELI LILLY & Co (LLY)
Filgotinib	Galapagos NV (GLPG)
guselkumab	JOHNSON & JOHNSON (JNJ)
guselkumab	GH Research PLC (GHRS)
Injection of triamcinolone acetonide into the CMC-1 joint	Cidara Therapeutics, Inc. (CDTX)
Ketorolac Injection	UNITED THERAPEUTICS Corp (UTHR)
Ketorolac Injection	Valneva SE (VALN)
onabotulinumtoxin A	Revance Therapeutics, Inc. (RVNC)
OnabotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)
Purified Cortophin Gel 80 U	ANI PHARMACEUTICALS INC (ANIP)
Purified Cortophin Gel, 40 U	ANI PHARMACEUTICALS INC (ANIP)
Recombinant Granulocyte Colony-Stimulating Factor	Cidara Therapeutics, Inc. (CDTX)
SGLT2 inhibitor	ELI LILLY & Co (LLY)
telitacicept	GH Research PLC (GHRS)
tnf inhibitor	ELI LILLY & Co (LLY)
tocilizumab	GH Research PLC (GHRS)
ustekinumab	GH Research PLC (GHRS)

Compare drugs

abrilada vs acetaminophen abrilada vs amjevita abrilada vs Brenzys (SB4)

Frequently asked questions

How many drugs are in development for Arthritis?

BioSniper tracks 224 drugs in development for Arthritis across 108 companies.

How many clinical trials target Arthritis?

There are 4 clinical trials targeting Arthritis tracked by BioSniper.

What is the prevalence of Arthritis?

The estimated prevalence of Arthritis is approximately 800.0 per 100,000 population.

Deep-dive into Arthritis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis